Literature DB >> 27737495

A countermeasure development pipeline.

Calum A MacRae1,2, Gerry Boss3, Matthew Brenner4, Robert E Gerszten5,6, Sari Mahon3, Randall T Peterson5,6.   

Abstract

We have developed an integrated pipeline for countermeasure discovery that, under the auspices of the National Institutes of Health Countermeasures Against Chemical Threats network, is one of the few efforts within academia that by design spans the spectrum from discovery to phase I. The successful implementation of this approach for cyanide would enable efficient proof-of-concept studies that would lay the foundation for a generalizable strategy for parallel mechanistic studies and accelerated countermeasure development in the face of new and emerging chemical threats.
© 2016 New York Academy of Sciences.

Entities:  

Keywords:  animal models; countermeasure; cyanide; drug discovery; metabolomics

Mesh:

Substances:

Year:  2016        PMID: 27737495      PMCID: PMC6420827          DOI: 10.1111/nyas.13224

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  2 in total

1.  Identification of specific metabolic pathways as druggable targets regulating the sensitivity to cyanide poisoning.

Authors:  Patrick Y Sips; Xu Shi; Gabriel Musso; Anjali K Nath; Yanbin Zhao; Jason Nielson; Jordan Morningstar; Amy E Kelly; Brittney Mikell; Eva Buys; Vikhyat Bebarta; Jared Rutter; V Jo Davisson; Sari Mahon; Matthew Brenner; Gerry R Boss; Randall T Peterson; Robert E Gerszten; Calum A MacRae
Journal:  PLoS One       Date:  2018-06-07       Impact factor: 3.240

2.  Intramuscular administration of hexachloroplatinate reverses cyanide-induced metabolic derangements and counteracts severe cyanide poisoning.

Authors:  Jordan Morningstar; Jangwoen Lee; Tara Hendry-Hofer; Alyssa Witeof; L Tiffany Lyle; Gregg Knipp; Calum A MacRae; Gerry R Boss; Randall T Peterson; Vincent J Davisson; Robert E Gerszten; Vikhyat S Bebarta; Sari Mahon; Matt Brenner; Anjali K Nath
Journal:  FASEB Bioadv       Date:  2018-10-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.